Tag: MDA
Biophytis presents the development of Sarconeos (BIO101) as a drug candidate in rare neuromuscular diseases at the Muscular Dystrophy Association (MDA) clinical and scientific conference – 03/20/2023 at 08:00
Paris (France), Cambridge (Massachusetts, United States)), March 20, 2023, 8:00 a.m. CET – Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a biotechnology company specializing in…